alkenes has been researched along with methotrexate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Jong, S; de Vries, EG; Mulder, NH; Zijlstra, JG | 1 |
| Divekar, AY; Fleysher, MH; Hakala, MT; Kenny, LN; Slocum, HK | 1 |
| Divekar, AY; Hakala, MT; Slocum, HK | 1 |
| Besserer, JA; Boritzki, TJ; Fry, DW | 1 |
| Brigle, KE; Goldman, ID; Sierra, EE; Spinella, MJ | 1 |
5 other study(ies) available for alkenes and methotrexate
| Article | Year |
|---|---|
Lack of cross-resistance to fostriecin in a human small-cell lung carcinoma cell line showing topoisomerase II-related drug resistance.
Topics: Alkenes; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Cell Line; Cell Nucleus; DNA Topoisomerases, Type II; Drug Resistance; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Methotrexate; Polyenes; Pyrones; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1991 |
Changes in sarcoma 180 cells associated with drug-induced resistance to adenosine analogs.
Topics: Adenosine; Alkenes; Aminohydrolases; Animals; Carbon Isotopes; Cell Division; Cells, Cultured; Chromatography, Paper; Cross Reactions; Deamination; Drug Resistance; Floxuridine; Furans; Inosine; Methotrexate; Mice; Pentosyltransferases; Phosphotransferases; Purines; Ribonucleosides; Sarcoma 180; Time Factors | 1972 |
N6-(delta2-isopentenyl)adenosine 5'-monophosphate: formation and effect on purine metabolism in cellular and enzymatic systems.
Topics: Adenine Nucleotides; Adenosine Monophosphate; Alkenes; Animals; Carbon Radioisotopes; Cells; Cells, Cultured; Chromatography, Paper; Glycine; Hypoxanthines; Inosine Nucleotides; Ketone Oxidoreductases; Ligases; Lyases; Methotrexate; Pentosyltransferases; Phosphotransferases; Purines; Sarcoma 180; Time Factors | 1974 |
Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system.
Topics: Alkenes; Animals; Biological Transport; Drug Resistance; Folic Acid; Kinetics; Leukemia L1210; Methotrexate; Mice; Polyenes; Pyrones; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase | 1984 |
Distinguishing between folate receptor-alpha-mediated transport and reduced folate carrier-mediated transport in L1210 leukemia cells.
Topics: Alkenes; Animals; Biological Transport; Carrier Proteins; Energy Metabolism; Folate Receptors, GPI-Anchored; Folic Acid; Hydrogen-Ion Concentration; Ions; Leukemia L1210; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Mice; Polyenes; Probenecid; Pyrones; Receptors, Cell Surface; Reduced Folate Carrier Protein; Sulfobromophthalein; Temperature; Transfection; Tumor Cells, Cultured | 1995 |